{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:16:22Z","timestamp":1771046182411,"version":"3.50.1"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Reactivation of Human Cytomegalovirus (HCMV) and Human Adenovirus (HAdV) in immunocompromised patients following stem cell transplantation (SCT) or solid organ transplantation (SOT) is associated with high morbidity and mortality. The adoptive transfer of virus-specific CD8<jats:sup>+<\/jats:sup> and CD4<jats:sup>+<\/jats:sup> T cells has been shown to re-establish the antiviral T-cell response and improve clinical outcome. The viral load in immunocompromised patients can efficiently be reduced solely by the infusion of virus-specific CD4<jats:sup>+<\/jats:sup> T cells. The identification of CD4<jats:sup>+<\/jats:sup> T-cell epitopes has mainly focused on a limited number of viral proteins that were characterized as immunodominant. Here, we used <jats:italic>in silico<\/jats:italic> prediction to determine promiscuous CD4<jats:sup>+<\/jats:sup> T-cell epitopes from the entire proteomes of HCMV and HAdV. Immunogenicity testing with enzyme-linked immuno spot (ELISpot) assays and intracellular cytokine staining (ICS) revealed numerous novel CD4<jats:sup>+<\/jats:sup> T-cell epitopes derived from a broad spectrum of viral antigens. We identified 17 novel HCMV-derived and seven novel HAdV-derived CD4<jats:sup>+<\/jats:sup> T-cell epitopes that were recognized by &amp;gt; 50% of the assessed peripheral blood mononuclear cell (PBMC) samples. The newly identified epitopes were pooled with previously published, retested epitopes to stimulate virus-specific memory T cells in PBMCs from numerous randomly selected blood donors. Our peptide pools induced strong IFN\u03b3 secretion in 46 out of 48 (HCMV) and 31 out of 31 (HAdV) PBMC cultures. In conclusion, we applied an efficient method to screen large viral proteomes for promiscuous CD4<jats:sup>+<\/jats:sup> T-cell epitopes to improve the detection and isolation of virus-specific T cells in a clinical setting.<\/jats:p>","DOI":"10.3389\/fimmu.2021.700438","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:20:56Z","timestamp":1625638856000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Broad and Efficient Activation of Memory CD4+ T Cells by Novel HAdV- and HCMV-Derived Peptide Pools"],"prefix":"10.3389","volume":"12","author":[{"given":"Alexander","family":"H\u00f6ttler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9o","family":"M\u00e4rz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"L\u00fcbke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Georg","family":"Rammensee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Stevanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609053351007","article-title":"Ganciclovir","volume":"335","author":"Crumpacker","year":"1996","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in Immunocompromised Hosts","volume":"21","author":"Echavarria","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1086\/508173","article-title":"Seroprevalence of Cytomegalovirus Infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.07.015","article-title":"Cmv-, EBV- and ADV-Specific T Cell Immunity: Screening and Monitoring of Potential Third-Party Donors to Improve Post-Transplantation Outcome","volume":"19","author":"Sukdolak","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.64.11.5457-5464.1990","article-title":"Efficacious Control of Cytomegalovirus Infection After Long-Term Depletion of CD8+ T Lymphocytes","volume":"64","author":"Jonjic","year":"1990","journal-title":"J Virol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.5.1232","article-title":"Direct Visualization of Cytomegalovirus-Specific T-Cell Reconstitution After Allogeneic Stem Cell Transplantation","volume":"97","author":"Cwynarski","year":"2001","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1086\/382964","article-title":"Results of a Cytomegalovirus (CMV)-Specific CD8+\/interferon- Gamma+ Cytokine Flow Cytometry Assay Correlate With Clinical Evidence of Protective Immunity in Patients With AIDS With CMV Retinitis","volume":"189","author":"Jacobson","year":"2004","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05331.x","article-title":"Detection of Adenovirus-Specific T Cells in Children With Adenovirus Infection After Allogeneic Stem Cell Transplantation","volume":"128","author":"Feuchtinger","year":"2005","journal-title":"Br J Haematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1352912","article-title":"Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.11.3916","article-title":"Infusion of Cytomegalovirus (CMV)-Specific T Cells for the Treatment of CMV Infection Not Responding to Antiviral Chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive Transfer of Pp65-Specific T Cells for the Treatment of Chemorefractory Cytomegalovirus Disease or Reactivation After Haploidentical and Matched Unrelated Stem Cell Transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of Minimally Manipulated CMV-Specific T Cells From Stem Cell or Third-Party Donors to Treat CMV Infection After Allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-573725","article-title":"Adoptive T-Cell Therapy With Hexon-Specific Th1 Cells as a Treatment of Refractory Adenovirus Infection After HSCT","volume":"125","author":"Feucht","year":"2015","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2003.12.009","article-title":"Isolation and Expansion of Human Adenovirus-Specific CD4+ and CD8+ T Cells According to IFN-Gamma Secretion for Adjuvant Immunotherapy","volume":"32","author":"Feuchtinger","year":"2004","journal-title":"Exp Hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe Adoptive Transfer of Virus-Specific T-Cell Immunity for the Treatment of Systemic Adenovirus Infection After Allogeneic Stem Cell Transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.9.5226-5240.2003","article-title":"Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers","volume":"77","author":"Elkington","year":"2003","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.10.049","article-title":"Ex Vivo Detection of Adenovirus Specific CD4+ T-Cell Responses to HLA-DR-Epitopes of the Hexon Protein Show a Contracted Specificity of T(HELPER) Cells Following Stem Cell Transplantation","volume":"397","author":"Serangeli","year":"2010","journal-title":"Virology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890430119","article-title":"Identification of the Major Late Human Cytomegalovirus Matrix Protein pp65 as a Target Antigen for CD8+ Virus-Specific Cytotoxic T Lymphocytes","volume":"43","author":"McLaughlin-Taylor","year":"1994","journal-title":"J\u00a0Med Virol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1086\/340637","article-title":"Cytomegalovirus (CMV) Phosphoprotein 65 Makes a Large Contribution to Shaping the T Cell Repertoire in CMV-Exposed Individuals","volume":"185","author":"Kern","year":"2002","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01689-07","article-title":"Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy","volume":"82","author":"Leen","year":"2008","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050882","article-title":"Broadly Targeted Human Cytomegalovirus-Specific CD4+ and CD8+ T Cells Dominate the Memory Compartments of Exposed Subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nri3152","article-title":"Expanding Roles for CD4(+) T Cells in Immunity to Viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00202","article-title":"The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People","volume":"10","author":"Lim","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1084\/jem.178.1.27","article-title":"Specificity and Promiscuity Among Naturally Processed Peptides Bound to HLA-DR Alleles","volume":"178","author":"Chicz","year":"1993","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/BF00188785","article-title":"Pool Sequencing of Natural HLA-DR, DQ, and DP Ligands Reveals Detailed Peptide Motifs, Constraints of Processing, and General Rules","volume":"39","author":"Falk","year":"1994","journal-title":"Immunogenetics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2010.03268.x","article-title":"MHC Class II Epitope Predictive Algorithms","volume":"130","author":"Nielsen","year":"2010","journal-title":"Immunology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: Database for MHC Ligands and Peptide Motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: A Worldwide Hub of Protein Knowledge","volume":"47","author":"UniProt","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1166","article-title":"Allele Frequency Net 2015 Update: New Features for HLA Epitopes, KIR and Disease and HLA Adverse Drug Reaction Associations","volume":"43","author":"Gonzalez-Galarza","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1745-7580-6-9","article-title":"NetMHCIIpan-2.0 - Improved Pan-Specific HLA-DR Predictions Using a Novel Concurrent Alignment and Weight Optimization Training Procedure","volume":"6","author":"Nielsen","year":"2010","journal-title":"Immunome Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1065369","DOI":"10.1080\/2162402X.2015.1065369","article-title":"HLA Ligandomics Identifies Histone Deacetylase 1 as Target for Ovarian Cancer Immunotherapy","volume":"5","author":"Peper","year":"2016","journal-title":"Oncoimmunology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI Search and Sequence Analysis Tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.04.028","article-title":"Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction","volume":"157","author":"Weekes","year":"2014","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update on Adenovirus and Its Vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J Gen Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.57.3.848-856.1986","article-title":"Biosynthesis of Adenovirus Type 2 I-Leader Protein","volume":"57","author":"Symington","year":"1986","journal-title":"J Virol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.68.7.4450-4457.1994","article-title":"The Product of the Adenovirus Intermediate Gene IVa2 Is a Transcriptional Activator of the Major Late Promoter","volume":"68","author":"Tribouley","year":"1994","journal-title":"J Virol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.80118-0","article-title":"Natural Variation Among Human Adenoviruses: Genome Sequence and Annotation of Human Adenovirus Serotype 1","volume":"85","author":"Lauer","year":"2004","journal-title":"J Gen Virol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013003","article-title":"Adenovirus DNA Replication","volume":"5","author":"Hoeben","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00018-004-4363-x","article-title":"Major Contribution of Codominant CD8 and CD4 T Cell Epitopes to the Human Cytomegalovirus-Specific T Cell Repertoire","volume":"62","author":"Nastke","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1151","article-title":"Clonotypic Structure of the Human CD4+ Memory T Cell Response to Cytomegalovirus","volume":"167","author":"Bitmansour","year":"2001","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh065","article-title":"Identification of New Th Peptides From the Cytomegalovirus Protein pp65 to Design a Peptide Library for Generation of CD4 T Cell Lines for Cellular Immunoreconstitution","volume":"16","author":"Li Pira","year":"2004","journal-title":"Int Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1089\/104303402320138952","article-title":"The Adenovirus Capsid Protein Hexon Contains a Highly Conserved Human CD4+ T-Cell Epitope","volume":"13","author":"Olive","year":"2002","journal-title":"Hum Gene Ther"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302316","article-title":"Adenovirus Hexon T-Cell Epitope Is Recognized by Most Adults and Is Restricted by HLA DP4, the Most Common Class II Allele","volume":"11","author":"Tang","year":"2004","journal-title":"Gene Ther"},{"key":"B45","unstructured":"Bioinformatics Tools Faq2019"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg500","article-title":"Multiple Sequence Alignment With the Clustal Series of Programs","volume":"31","author":"Chenna","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191164","article-title":"Identification of HCMV-Derived T Cell Epitopes in Seropositive Individuals Through Viral Deletion Models","volume":"217","author":"Lubke","year":"2020","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00531.x","article-title":"A HCMV pp65 Polypeptide Promotes the Expansion of CD4+ and CD8+ T Cells Across a Wide Range of HLA Specificities","volume":"13","author":"Provenzano","year":"2009","journal-title":"J Cell Mol Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nri2274","article-title":"T-Cell Quality in Memory and Protection: Implications for Vaccine Design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.70.11.7569-7579.1996","article-title":"The Human Cytotoxic T-lymphocyte (CTL) Response to Cytomegalovirus Is Dominated by Structural Protein pp65: Frequency, Specificity, and T-Cell Receptor Usage of pp65-Specific Ctl","volume":"70","author":"Wills","year":"1996","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.10.8179-8184.1999","article-title":"Target Structures of the CD8(+)-T-Cell Response to Human Cytomegalovirus: The 72-Kilodalton Major Immediate-Early Protein Revisited","volume":"73","author":"Kern","year":"1999","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/j.1600-6143.2007.01890.x","article-title":"Inconsistent Responses of Cytomegalovirus-Specific T Cells to pp65 and IE-1 Versus Infected Dendritic Cells in Organ Transplant Recipients","volume":"7","author":"Lilleri","year":"2007","journal-title":"Am J Transplant"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.018994-0","article-title":"Sequential Mutations Associated With Adaptation of Human Cytomegalovirus to Growth in Cell Culture","volume":"91","author":"Dargan","year":"2010","journal-title":"J Gen Virol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1128\/jvi.70.1.78-83.1996","article-title":"Human Cytomegalovirus Clinical Isolates Carry at Least 19 Genes Not Found in Laboratory Strains","volume":"70","author":"Cha","year":"1996","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18952-0","article-title":"Two Novel Spliced Genes in Human Cytomegalovirus","volume":"84","author":"Akter","year":"2003","journal-title":"J Gen Virol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6639a2","article-title":"Human Adenovirus Surveillance - United States, 2003-2016","volume":"66","author":"Binder","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.5.1090","article-title":"Characterization of Human Proliferative T Cell Responses to Adenovirus","volume":"171","author":"Flomenberg","year":"1995","journal-title":"J Infect Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.10-1419","article-title":"Extensive Cross-Reactivity of Adenovirus-Specific Cytotoxic T Cells","volume":"9","author":"Smith","year":"1998","journal-title":"Hum Gene Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.11.6562-6566.2003","article-title":"Extensive Cross-Reactivity of CD4+ Adenovirus-Specific T Cells: Implications for Immunotherapy and Gene Therapy","volume":"77","author":"Heemskerk","year":"2003","journal-title":"J Virol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.091","article-title":"Adenovirus-Specific Human T Cells Are Pervasive, Polyfunctional, and Cross-Reactive","volume":"28","author":"Hutnick","year":"2010","journal-title":"Vaccine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14347","article-title":"An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.700438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T13:44:23Z","timestamp":1626097463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.700438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2021.700438"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.700438","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"article-number":"700438"}}